- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Stable Growth Stocks
Hong Kong Pharmaceuticals & Biotech Stable Growth Stocks
Results
5
5 companies
3SBio
Market Cap: HK$45.8b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$19.44
7D
-1.6%
1Y
208.1%
Hansoh Pharmaceutical Group
Market Cap: HK$157.3b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$26.45
7D
1.5%
1Y
48.1%
Shanghai Henlius Biotech
Market Cap: HK$24.7b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$45.45
7D
2.5%
1Y
n/a
WuXi XDC Cayman
Market Cap: HK$49.3b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$41.00
7D
2.1%
1Y
164.5%
Grand Pharmaceutical Group
Market Cap: HK$30.0b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.
512
HK$8.57
7D
-1.7%
1Y
77.8%